Evidence map›Paper›PMID 31593573›Full record

ArticlePloS one2019

A novel short-term high-lactose culture approach combined with a matrix-assisted laser desorption ionization-time of flight mass spectrometry assay for differentiating Escherichia coli and Shigella species using artificial neural networks.

Jin Ling, Hong Wang, Gaomin Li, Zhen Feng, Yufei Song, Peng Wang, Hong Shao, Hu Zhou, Gang Chen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Non-lactose fermentingFrontiers in microbiology · 2022
    Article
  4. Historical, current, and emerging tools for identification and serotyping of Shigella.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jin LingDepartment of Biochemical Drugs and Biological Products, Shanghai Institute for Food and Drug Control, Shanghai, China.
Hong WangDepartment of Biochemical Drugs and Biological Products, Shanghai Institute for Food and Drug Control, Shanghai, China.
Gaomin LiDepartment of Biochemical Drugs and Biological Products, Shanghai Institute for Food and Drug Control, Shanghai, China.
Zhen FengDepartment of Antibiotics and Microbiology, Shanghai Institute for Food and Drug Control, Shanghai, China.
Yufei SongDepartment of Gastroenterology, Lihuili Hospital of Ningbo Medical Center, Ningbo, China.
Peng WangShanghai Key Laboratory of Intelligent Information Processing, School of Computer Science, Fudan University, Shanghai, China.
Hong ShaoDepartment of Biochemical Drugs and Biological Products, Shanghai Institute for Food and Drug Control, Shanghai, China.
Hu ZhouDepartment of Analytical Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Gang ChenDepartment of Biochemical Drugs and Biological Products, Shanghai Institute for Food and Drug Control, Shanghai, China.ORCID 0000-0002-2163-9992
ZheJiang Institute For Food and Drug Control · CNChinese Academy of Sciences · CNFudan University · CNGuang Fu Hospital · CNNingbo Medical Center Lihuili Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEscherichia coli is currently unable to be reliably differentiated from Shigella species by routine matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis. In the present study, a reliable and rapid identification method was established for Escherichia coli and Shigella species based on a short-term high-lactose culture using MALDI-TOF MS and artificial neural networks (ANN). MATERIALS AND

methodsThe Escherichia coli and Shigella species colonies, treated with (Condition 1)/without (Condition 2) a short-term culture with an in-house developed high-lactose fluid medium, were prepared for MALDI-TOF MS assays. The MS spectra were acquired in linear positive mode, with a mass range from 2000 to 12000 Da and were then compared to discover new biomarkers for identification. Finally, MS spectra data sets 1 and 2, extracted from the two conditions, were used for ANN training to investigate the benefit on bacterial classification produced by the new biomarkers.

resultsTwenty-seven characteristic MS peaks from the Escherichia coli and Shigella species were summarized. Seven unreported MS peaks, with m/z 2330.745, m/z 2341.299, m/z 2371.581, m/z 2401.038, m/z 3794.851, m/z 3824.839 and m/z 3852.548, were discovered in only the spectra from the E. coli strains after a short-term high-lactose culture and were identified as belonging to acid shock protein. The prediction accuracies of the ANN models, based on data set 1 and 2, were 97.71±0.16% and 74.39±0.34% (n = 5), with an extremely remarkable difference (p < 0.001), and the areas under the curve of the receiver operating characteristic curve were 0.72 and 0.99, respectively.

conclusionsIn summary, adding a short-term high-lactose culture approach before the analysis enabled a reliable and easy differentiation of Escherichia coli from the Shigella species using MALDI-TOF MS and ANN.

Indexed as

Cell Culture TechniquesEscherichia coliLactoseNeural Networks, ComputerShigellaSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationLactose

Identifiers

PMID31593573
PMCPMC6782097
OpenAlexW2979662298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.